ELYM (Eliem Therapeutics) Yalpi marja

Eliem Therapeutics Inc. (ELYM) korporativ emblemasi va logotipi

Eliem Therapeutics (ELYM) Tenet bilan birlashganidan so'ng, TNT119 innovatsion dori vositasi va moliyaviy qo'llab-quvvatlashga tayanmoqda. Tushumning yalpi foyda marjasi ulushi joriy dinamikani aks ettirib, ushbu ko'rsatkich 0.00 darajasida turibdi. Biroq, barqaror daromad oqimlarining yo'qligi kompaniyani tashqi kapitalga bog'liq qiladi, R&D xarajatlarining yuqoriligi va klinik sinovlarning noaniqligi esa sezilarli biznes risklarini yuzaga keltirmoqda.

eliemtx.com - ELYM Yalpi marja (davr: 04.07.2022 - 03.10.2024)

eliemtx.com (ELYM) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Fundamental baholash:ELYM - Eliem Therapeutics
Eliem Therapeutics ishlab chiqargan mahsulot

Eliem Therapeutics kompaniyasining neyrobiologik platformalarga bo'lgan noyob patent huquqlari raqobatchilar uchun kirishning yuqori to'sig'ini yaratadi. Valo martoza (gross margin) tushumning bevosita ishlab chiqarish xarajatlari chegirib tashlangan qismini o'lchaydi va intellektual mulkni monetizatsiya qilish samaradorligini aks ettiradi. Bazaviy valo martoza tendentsiyasi investorlarga biznesning xarajatlar oshishiga nisbatan barqarorligini baholash hamda operatsion ishonchlilik va kapitalizatsiya o'sishi potentsiali o'rtasidagi muvozanatni aniqlash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|ACIU: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VYGR (Voyager Corp)|Yalpi foyda bo'yicha rentabellik Neumora NMRA|Yalpi rentabellik Scilex Holding Company, Inc. SCLX|Sotuvning yalpi marjinal rentabelligi Tevogen Bio Inc.|ACOG - Yalpi rentabellik|Sotuvning yalpi marjinal rentabelligi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Yalpi foyda bo'yicha rentabellik|Cassava Sciences Inc (SAVA) - Yalpi marja|Yalpi foyda bo'yicha rentabellik ASRT|Yalpi marja coyatherapeutics.com|Yalpi marja VTGN|Ovid Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Yalpi foyda bo'yicha rentabellik|ATHE - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi clene.com CLNN|PEPG: Yalpi marja|Sotuvning yalpi rentabelligi JUNS|RLMD (Relmada Corp) - Yalpi marja|Annovis Bio Inc (ANVS) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Yalpi foyda normasi|Yalpi rentabellik Klotho Neurosciences KLTO|NRSN: Sotuvning yalpi rentabelligi|RVPH: Yalpi foyda bo'yicha rentabellik|MTVA: Yalpi rentabellik|NRXS (NeurAxis Inc) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Helius Medical Technologies, Inc.|Yalpi rentabellik Passage Bio Inc.|Yalpi foyda marjasi bionomics.com.au NEUP|Yalpi marja NERV|Yalpi marja Athira Pharma Inc (ATHA)|Yalpi marja ADXN (Addex Therapeutics Ltd.)|ALZN: Sotuvning yalpi rentabelligi|CYCN - Yalpi rentabellik|Yalpi foyda marjasi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Yalpi foyda bo'yicha rentabellik|Sotuvning yalpi marjinal rentabelligi Cortigent, Inc. CRGT|Yalpi rentabellik Avenue Therapeutics, Inc.|Yalpi foyda bo'yicha rentabellik BrainStorm Cell Therapeutics Inc. (BCLI)|Yalpi rentabellik Cara Therapeutics, Inc (CARA)|Yalpi rentabellik CHRO (Chromocell Therapeutics Corp.)|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)